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Original article
Purpose: Rathke’s cleft cyst (RCC) is an asymptomatic benign lesion. With increased 
interest in pediatric endocrinology, the prevalence of RCCs in children is also 
increasing. However, the clinical relevance and proper management of RCC is not 
well defined in children. Therefore, we investigated the clinical manifestations 
and radiologic features of RCC in children and adolescents, as well as the natural 
progression of RCC.
Methods: We retrospectively reviewed the medical records of 91 children and 
adolescents with RCC diagnosed with magnetic resonance imaging (MRI) in 
Severance Children’s Hospital from January 2006 to December 2015. The clinical, 
hormonal, and imaging findings were analyzed in patient groups classified 
according to age. The size of each cyst was assessed in sixty patients who 
underwent follow-up MRI during the 2 years.
Results: Female patients were predominant (64 vs. 27). The common clinical 
features at presentation were endocrine dysfunction (59.3%), headache (23.0%), 
and dizziness (4.4%). Symptoms related to endocrine disorders were more frequent 
in younger patients. In 7 patients managed surgically, the cysts were significantly 
larger and more frequently located in the suprasellar region. Of 60 nonsurgical 
patients with a follow-up MRI performed within 2 years after the diagnosis, the RCC 
size increased in about 26.7% (n=16).
Conclusion: Although 94.4% of the patients with RCC had clinical symptoms, 
surgery was performed in only about 7.5% of patients. RCC is associated with 
pituitary insufficiency, thus, baseline and follow-up endocrine function tests are 
required. Additionally, regular MRI follow-up is required in long-term period to 
monitor change in size.
Keywords: Central nervous system cysts, Child, Adolescent, Endocrine system 
diseases, Hormones, Natural history
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Introduction
Rathke’s cleft cyst (RCC) is a benign, sellar, and/or suprasellar lesion originating from the 
remnants of Rathke's pouch, which disappears during the embryonic period1,2). RCCs are 
usually found incidentally in adults, with an incidence of about 12%–33% in autopsy cases3-6). 
Although most cases of RCC are asymptomatic, some RCCs progress to enlarged cysts, leading 
to compression of adjacent structures and resulting in clinical symptoms such as headache, 
visual disturbance, and endocrinopathy. It is also assumed that the change of cyst in the size 
would be related to an imbalance between the secretion and absorption of cyst contents, and 
may cause leakage, intracystic hemorrhage, and infection7,8). 
Recently, the prevalence of RCC in children is gradually increasing, owing to the increased 
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number of  work-ups for detecting growth and puberty 
disorders in children, as well as the improved quality of brain 
imaging, allowing the identifi cation of RCC. However, most 
previous studies on RCC were based on adult data, and the 
number of enrolled patients was limited. In addition, the 
optimal guideline for the management of asymptomatic RCC 
is not well defined because of the uncertainty about the natural 
course of asymptomatic RCC.
In the present study, we aimed to investigate the clinical 
characteristics of RCC in children and adolescents, and the 
natural course of asymptomatic RCC in patients undergoing 
brain magnetic resonance imaging (MRI) at least 2 times during 
2 years. 
Materials and methods
1. Patients
Ninety-one patients with RCC (age, 1–18 years) who visited 
Severance Children’s Hospital from January 2006 to December 
2015 were included. RCC was diagnosed in these patients 
based on the results of sellar MRI. This study's protocol was 
approved by the Institutional Review Board of Yonsei University 
Severance Hospital (approval number: 4-2017-0121). Written 
informed consent was obtatined from all patients.
2. Analysis of clinical and radiological data
We obtained the baseline information of patients, including 
clinical symptoms, age, sex, height, weight, and body mass 
index, through a retrospective review of medical records. The 
patients were categorized according to age at diagnosis into the 
school-age group (subdivided into elementary and middle or 
high school) and the preschool-age group. The height standard 
deviation score (SDS) and weight SDS were adjusted for 
chronological age (CA) and sex were calculated by using the 
2007 growth reference for Korean children and adolescents. 
Endocrinological evaluation included measurement of the 
bone age (BA) and the basal level of free thyroxine, thyroid-
stimulating hormone (TSH), insulin-like growth factor-I, 
insulin-like growth factor binding protein-3, luteinizing 
hormone (LH), follicle stimulating hormone (FSH), estradiol, 
testosterone, adrenocorticotropic hormone (ACTH), cortisol, 
and prolactin. Some selected cases required more detailed 
examinations, such as a combined pituitary function test or a 
gonadotropin releasing hormone (GnRH) stimulation test.  
The following criteria were used for the diagnosis of various 
endocrine disorders. The definition of  growth hormone 
deficiency (GHD) included (1) short stature, below the third 
percentile for age or >2 standard deviations below the mean 
stature; (2) a peak growth hormone (GH) level of <10 ng/
mL in 2 types of GH stimulation tests, by using levodopa and 
insulin; and (3) delayed BA comparing to CA. The criteria for 
the diagnosis of central precocious puberty (CPP) were (1) 
onset of pubertal characteristics before the age of 8 years in girls 
and 9 years in boys; (2) a peak LH level of >5 mIU/mL in the 
GnRH stimulation test; and (3) advanced BA comparing to CA. 
TSH deficiency was defined as the absence of a TSH increase 
during the thyrotropin releasing hormone stimulation test. 
ACTH deficiency was diagnosed when no increase in cortisol 
was elicited during the insulin tolerance test (peak cortisol level, 
<20 µg/dL). Lastly, hyperprolactinemia was defined as a baseline 
prolactin level of >25 ng/mL. 
Diabetes insipidus (DI) was defined to the disease with 
polyuria and polydipsia which is originated from the deficiency 
of antidiuretic hormone.
The MRI findings of  RCCs, confirmed by neurolog y 
radiologists, were classified based on different characteristics, 
such as the size (height and width), location, and signal 
intensities of T1- and T2-weighted images (high, equal, and 
low).
3. Statistical analysis
All statistical analyses were conducted with IBM SPSS 
Statistics ver. 20.0 (IBM Co., Armonk, NY, USA). Continuous 
variables such as age, height, and weight are presented as the 
mean±standard. Categorical variables such as sex, clinical 
symptoms at diagnosis and MRI findings were expressed by 
using frequencies and percentages and were compared with 
Table 1. Demographic and clinical characteristics of the 91 
patients included in the analysis
Characteristic Value
Age (yr), mean±SD (range) 9.7±4.2 (1.2–18.0)
Sex
  Male 27 (29.7)
  Female 64 (70.3)
Height SDS 0.37±1.51
Weight SDS 0.30±1.27
Body mass index SDS 0.11±1.12
Endocrinologic abnormality , n (%) 54 (59.3)
Early puberty 34
  Short stature 13
  Polyuria 4
Galactorrhea 2
  Menstrual problem 1
Neurologic abnormality , n (%) 32 (35.1)
  Headache 21
  Dizziness 4
  Visual disturbance 3
  Syncope 2
  Seizure 1
  Tinnitus 1
Asymptomatic, n (%) 5 (5.6)
Treatment
  Conservative management 84
   Surgical management 7
SDS, standard deviation score.
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other variables by using chi-square test. A P-value of <0.05 was 
considered significant.
Results
1. Baseline clinical characteristics of RCC
The demographic and clinical characteristics of 91 patients 
are shown in Table 1. Of total patients, 27 were boys (29.7%) 
and 64 were girls (70.3%). The mean age of the patients was 
9.7 years (range, 1.2–18.0 years). More than half of the patients 
had symptoms related to the endocrine system (n=54, 59.3%), 
such as early puberty, short stature, polyuria, galactorrhea, 
and menstrual disturbance. Thirty-two patients (35.1%) had 
symptoms related to the neurologic system, such as headache 
(n=21, 23.1%), dizziness (n=4, 4.4%), and visual disturbance 
(n=3, 3.3%). In addition, asymptomatic patient was 5 (5.6%) 
(Table 1).
Fifty-one patients performed endocrinologic function 
test and Table 2 summarized the results. The most common 
endocrine dysfunction was CPP (n=36, 70.6%, 33 isolated, 3 
combined endocrinopathy), followed by GHD (n=14, 27.5%,  5 
isolated, 9 combined endocrinopathy), DI (n=3, 5.9%, 1 isolated, 
2 combined endocrinopathy), hyperprolactinemia (n=2, 3.9%, 
1 isolated, 1 combined endocrinopathy), ACTH deficiency 
(n=1, 2.0%, 1 combined endocrinopathy) and gonadotropin 
deficiency (n=1, 2.0%, 1 combined endocrinopathy. Only 1 
patient (2.0%) of them had normal results.
Ten of 91 patients (11.0%) were multiple endocrine dysfunc-
tion; three patients of GHD with CPP, 2 patients of GHD 
with DI, 2 patients of GHD with TSH deficiency, 1 patient of 
GHD, TSH deficiency with ACTH deficiency, 1 patient of TSH 
deficiency accompanying hyperprolactinmeia and 1 patient 
of GHD, TSH deficiency, and accompanying gonadotropin 
deficiency.
 
2. Clinical manifestations in the groups classified 
    according to age
The presenting symptoms according to age group were 
analyzed (Table 3). In the preschool-age group (<7 years), early 
puberty (n=12, 46.2%), short stature (n=5, 19.2%), and headache 
(n=7, 27.0%) were common symptoms. Elementary-school 
children (7–12 years) also had symptoms of early puberty (n=22, 
48.8%) and short stature (n=5, 11.0%), but presented with a 
greater variety of neurological symptoms than the other groups. 
Lastly, the middle school or high school group (>12 years) 
mainly experienced neurological symptoms, such as headache 
(n=9, 45.0%). Clinical symptoms related to endocrine system, 
especially related to growth and puberty appeared significantly 
more frequent in before-middle school patients than in middle 
or high school aged patients (P<0.01). 
3. Clinical characteristics of the patients 
    who underwent surgery
Seven patients underwent surgical treatment, either in an 
attempt to resolve pressure symptoms such as headache and 
visual field defect or to investigate the possibility of malignancy 
(Table 4). In all 7 patients who underwent surgery, the selected 
Table 2. Results of endocrine evaluation in 51 patients
Variable Total Isolated Combined
Central precocious puberty 36 33 3
Growth hormone deficiency 14 5 9
TSH deficiency 5 0 5
Diabetes insipidus 3 1 2
Hyperprolactinemia 2 1 1
ACTH deficiency 1 0 1
Gonadotropin deficiency 1 0 1
Normal 1 - -
RCC, Rathke’s cleft cyst; TSH, thyroid stimulating hormone; ACTH, 
adenocorticotropic hormone.
Table 3. The incidence of chief complaints in patients with RCC, stratified to age group
Variable Preschool (<7 yr, n=26) Elemantary school (7–12 yr, n=45) Middle or high school (>12 yr, n=20) P-value
Endocrine (n=54, 59.3%) <0.01
  Short stature 5 (19.2) 5 (11.0) 3 (15.0)
  Early puberty 12 (46.2) 22 (48.8) 0 (0)
  Dysmenorrhea 0 (0) 0 (0) 1 (5.0)
  Polyuria 0 (0) 3 (6.7) 1 (5.0)
  Galactorrhea 0 (0) 0 (0) 2 (10.0)
Neurologic (n=32, 35.1%) 0.130
  Headache 7 (27.0) 5 (11.0) 9 (45.0)
  Dizziness 0 (0) 3 (6.7) 1 (5.0)
  Syncope 0 (0) 1 (2.2) 1 (5.0)
  Seizure 1 (3.8) 0 (0) 0 (0)
  Tinnitus 0 (0) 1 (2.2) 0 (0)
  Visual disturbance 0 (0) 2 (4.5) 1 (5.0)
  Asymptomatic (n=5, 5.5%) 1 (3.8) 3 (6.7) 1 (5.0) 0.33
Values are presented as number (%).
RCC, Rathke’s cleft cyst.
167
Jung JE, et al. • Features of Rathke’s cleft cysts in children
www.e-apem.org
operation method was transsphenoidal aspiration and the 
RCC was confirmed pathologically. After the operation, clinical 
symptoms related to pressure were improved after surgery 
in all 7 patients. On the other hand, the endocrine functions 
were aggravated in 2 of 7 patients, improved in 1 patient, and 
remained the same in 4 patients after surgery (Table 4). None of 
the 7 patients experienced recurrence of RCC. 
We also analyzed the characteristics of RCC comparing 2 
groups, surgical treatment group and nonsurgical treatment 
group. The RCC size of patients who required surgery was 
significantly larger than that of patients who did not underwent 
surgery (Table 5). Moreover, the RCC was more frequently 
located in suprasellar in patients who required surgical 
treatment. However, there were no differences signal intensities 
between surgical and nonsurgical group.
4. Natural progression of RCC size on image study of
    during 2 years
Sixty patients among total 31 patients underwent follow-
up MRIs during 2 years. Follow-up MRIs showed that the size 
of RCCs increased in 16 of 60 patients (26.7%), remained the 
same in 21 patients (48.3%), and decreased in 15 of 60 patients 
(25.0%). None of the patients with increased size of RCCs 
needed the surgical treatment in follow-up period.
Discussion
We evaluated the clinical characteristics of 91 children and 
adolescents with RCCs diagnosed with sellar MRI, and analyzed 
the presenting symptoms in the groups classified according 
to age. Our study demonstrated a female preponderance in 
RCC, as in previous studies of adults9,10). Presenting symptoms 
related to CPP, which is more common in girls than in boys, and 
menstrual disorders which are also presented only in girls may 
lead to frequent detection of RCC in female. On the other hand, 
the most 2 common chief complaints of boys were short stature 
(37.0%) and headache (25.9%), differently from those of girls 
early puberty (48.4%) and headache (23.4%). 
In this study, symptomatic RCC was noted in most of the 
patients (86 of 91 patients, 94.4%), whereas asymptomatic RCC 
was observed in only 5.6% (5 of 91 patients). The frequency of 
each symptom in symptomatic RCC patients has been reported 
to be variable owing to the diversity of the enrolled patient 
cohorts8,9,11-13). Previous studies of adults’ data reported that 
frequent clinical symptoms of RCC include headache, visual 
disturbance, and pituitary dysfunction. The prevalence of each 
clinical symptom showed wide ranges according to studies. 
Headache appeared in 44%–81% of patients, visual disturbance 
in 11%–67%, and pituitary dysfunction in 30%–60% of 
symptomatic cases9,10). In the present study, headache (n=21, 
23.1%) and visual disturbance (n=3, 3.3%) were less frequently 
observed, and pituitary dysfunction (n=54, 59.3%) showed a 
similar incidence to that reported in previous studies. Especially, 
pituitary dysfunction related to growth or puberty, such as 
short stature and early puberty appeared to only children 
or adolescents of our study differed from previous studies. 
Furthermore, analysis of the presenting neurologic symptoms in 
the groups classified according to the age showed that headache 
Table 4. Characteristics of seven patients who underwent surgery 
Patient No. Age (yr)/sex Reason for surgery Outcome Cyst size(height×width, mm)
Preop endocrine 
disorder
Postop endocrine 
disorder Recurrence
1 9/F Headache Improved 14.2×19.1 GHD Multiple* No
2 15/M Headache Improved 13.3×9.4 GHD Multiple† No
3 10/M Visual field defect Improved 28×18.1 Multiple‡ Multiple‡ No
4 10/F Suspected malignancy None 11.7×17.1 Normal Normal No
5 15/F Suspected malignancy, 
headache
Improved 8.2×11.1 GHD Normal No
6 18/M Suspected malignancy, 
headache
Improved 8.6×15.7 Multiple† Multiple† No
7 12/F Visual field defect Improved 18.2×20.1 Multiple‡ Multiple‡ No
Preop, preoperative; postop, postoperative; GHD, growth hormone deficiency.
*GHD, thyroid stimulating hormone deficiency, and gonadotropin deficiency. †GHD, adrenocorticotropic hormone deficiency, and thyroid stimulating 
hormone deficiency. ‡GHD and diabetes insipidus.
Table 5. Comparison of magnetic resonance imaging findings 
between the surgical and medical management groups
Variable Medical (n=84)
Surgical 
(n=7) P-value
Size, height (mm) 6.4±3.5 14.0±7.2 0.05
Size, width (mm) 10.1±3.7 15.0±4.1 <0.01
Location <0.01
  Suprasella 8 (9.5) 3 (42.8)
  Pars intermedia + supra extension 3 (3.6) 2 (28.6)
  Pars intermedia 73 (86.9) 2 (28.6)
T1 intensity 0.07
  Hypointense 23 (27.4) 0 (0)
  Isointense 13 (15.5) 4 (57.1)
  Hyperintense 48 (57.1) 3 (42.9)
T2 intensity 0.16
  Hypointense 68 (81.0) 4 (57.1)
  Isointense 8 (4.5) 2 (28.6)
  Hyperintense 8 (4.5) 1 (14.3)
Values are presented as mean±standard deviation or number (%).
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and visual disturbance were more common in older children 
and adolescents, however it does not have significant difference. 
Further hormonal study revealed that most of the patients 
(98.0%) had pituitary dysfunction, which manifested as 
CPP, GH deficiency, multiple pituitary hormone deficiency, 
hyperprolactinemia, and DI. According to the previous several 
studies of adults, prevalence of pituitary dysfunction in adults 
ranged from 30.0%–100.0%14). 
In previous studies, the indications for the surgical treat-
ment of patients with RCC were controversial. Although 
the conventional therapy for symptomatic RCCs is surgical 
resection, not all cases of symptomatic RCCs require surgery for 
resection–only RCCs with pressure symptoms require surgery. 
Conservative care with follow-up MRI is recommended in cases 
of silent RCCs or smaller cysts with mild symptoms, and surgery 
is preferable for larger cysts with definite pressure symptoms15). 
In our study, 7 patients were operated by transsphenoidal 
microscopic surgery either to alleviate pressure symptoms 
or to investigate the possibility of malignancy because of the 
increasing size of the RCC. RCC was confirmed pathologically 
in each of these cases. All 7 patients experienced improvement 
of clinical symptoms after surgery; however, their endocrine 
dysfunctions did not improve, or was even aggravated in 2 
patients. This is one of the reasons for the controversy about 
the operative treatment of RCC. Because radical resection 
may lead to a lower recurrence and a higher risk of additional 
endocrine disorders, transsphenoidal microscopic surgery 
is the first choice for surgical treatment12,16,17). In addition, 
follow-up endocrine surveillance is needed after surgical 
interventions. The several MRI features differed significantly 
between patients who underwent surgery and those who did 
not. RCCs were significantly larger and were more frequently 
located in the suprasellar region in patients who underwent 
surgery. Otherwise, we could not find any difference of intensity 
in the T1- or T2-weighted MRI images between patients who 
underwent surgery and those who did not. RCCs usually appear 
as homogenous intensity in the region of the pars intermedia7). 
The homogeneous signal observed in MRI can vary depending 
on the concentration and composition of the cyst contents, 
particularly protein, cholesterol, and hemorrhage18-20). Cysts with 
high protein contents display high intensity in T1-weighted 
images, and cysts with low water content show low intensity in 
T2-weighted images21,22). Lesions with high or low intensity in 
T1-weighted images and low intensity in T2-weighted images 
were most common in our study and consistent with findings 
reported in the literature22,23). 
Lastly, follow-up MRI was performed in sixty of the 91 
patients during 2 years, which showed that the size of RCC 
increased in 16 of 60 patients (26.7%), remained the same in 
29 of 60 patients (48.3%), and decreased in 15 of 60 patients 
(25.0%). Our study demonstrated that most cases of RCCs 
without pressure symptoms remain the same or decrease in size 
over time. Further studies about the effect of medical treatment 
on RCC are required.
Considering limitations of our study, according to age and 
symptoms related to RCCs which the patients already had, 
selection bias could develop.
In conclusion, it is necessary to perform both baseline 
and routine follow-up endocrine testing to detect endocrine 
dysfunction, because many patients with RCC may have 
symptoms related to pituitary dysfunction. Surgical resection 
is required only in RCC cases with pressure symptoms and 
conservative management of patients with RCC is recommen-
ded, in the absence of pressure symptoms. In addition, follow-
up MRI is required, because the size of RCC can change after 
few years.
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